Skip to main content

Table 3 Cardiopulmonary exercise testing parameters of the CHF patients with non-reduced LVEF (≥ 40%) or reduced LVEF (< 40%)

From: Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction

 

LVEF ≥ 40%

LVEF < 40%

All (n = 131)

Diabetic (n = 34)

Nondiabetic (n = 97)

Unadjusted mean difference (95% CI)

Adjusted mean difference (95% CI)

All (n = 144)

Diabetic (n = 44)

Nondiabetic (n = 100)

Unadjusted mean difference (95% CI)

Adjusted mean difference (95% CI)

Peak VO2, mL/kg/min

16.87 ± 4.98

15.16 ± 3.82

17.46 ± 5.22

− 1.15* (− 2.12 to − 0.18)

− 0.93* (− 1.82 to − 0.04)

15.52 ± 5.17

13.46 ± 3.94

16.43 ± 5.41

− 1.48* (− 2.38 to − 0.59)

− 1.05* (− 1.96 to − 0.15)

Peak workload, watts

91.0 ± 40.2

90.1 ± 43.2

91.4 ± 39.3

− 0.6 (− 8.6 to 7.4)

− 0.2 (− 6.6 to 6.3)

84.2 ± 34.1

76.9 ± 27.8

87.3 ± 36.1

− 5.2 (− 11.3 to 0.9)

− 2.5 (− 8.0 to 3.1)

Peak HR, beats/min

123.8 ± 30.7

116.5 ± 29.8

126.4 ± 30.7

− 5.0 (− 11.0 to 1.1)

− 2.4 (− 8.7 to 4.0)

120.7 ± 28.8

116.0 ± 24.5

122.8 ± 30.4

− 3.4 (− 8.5 to 1.7)

3.5 (− 2.0 to 9.0)

Peak RER

1.24 ± 0.13

1.19 ± 0.12

1.26 ± 0.13

− 0.04* (− 0.06 to − 0.01)

− 0.04* (− 0.06 to − 0.01)

1.26 ± 0.12

1.28 ± 0.13

1.25 ± 0.11

0.01 (− 0.01 to 0.04)

0.02 (− 0.01 to 0.04)

ΔVO2/Δworkload

7.21 ± 2.09

6.79 ± 1.99

7.35 ± 2.11

− 0.28 (− 0.69 to 0.13)

− 0.13 (− 0.54 to 0.27)

7.04 ± 1.90

6.65 ± 1.78

7.21 ± 1.94

− 0.28 (− 0.62 to 0.07)

− 0.29 (− 0.65 to 0.07)

Peak O2 pulse, mL/beats

8.77 ± 3.02

9.28 ± 3.28

8.59 ± 2.92

0.34 (− 0.25 to 0.94)

0.21 (− 0.23 to 0.66)

8.52 ± 2.90

7.98 ± 2.88

8.75 ± 2.89

− 0.38 (− 0.90 to 0.13)

− 0.75* (− 1.24 to − 0.25)

HR reserve, beats/min

55.8 ± 26.2

49.1 ± 25.3

58.2 ± 26.3

− 4.6 (− 9.7 to 0.6)

− 3.2 (− 8.8 to 2.3)

51.5 ± 25.3

47.9 ± 22.3

53.2 ± 2 6.4

− 2.7 (− 7.2 to 1.9)

1.7 (− 3.4 to 6.9)

Chronotropic index

0.60 ± 0.29

0.57 ± 0.33

0.62 ± 0.28

− 0.02 (− 0.08 to 0.04)

− 0.02 (− 0.08 to 0.05)

0.54 ± 0.27

0.52 ± 0.24

0.55 ± 0.28

− 0.01 (− 0.06 to 0.03)

0.03 (− 0.03 to 0.08)

AT VO2, mL/kg/min

10.75 ± 2.74

9.79 ± 1.59

11.09 ± 2.97

− 0.65* (− 1.18 to − 0.12)

− 0.65* (− 1.21 to − 0.08)

9.76 ± 2.62

8.78 ± 2.15

10.19 ± 2.70

− 0.71* (− 1.16 to − 0.25)

− 0.66* (− 1.11 to − 0.21)

Lowest VE/VCO2

33.6 ± 6.1

34.0 ± 4.4

33.4 ± 6.6

0.3 (− 0.9 to 1.5)

0.2 (− 0.9 to 1.4)

36.3 ± 8.2

37.9 ± 8.9

35.6 ± 7.8

1.1 (− 0.3 to 2.6)

0.6 (− 1.0 to 2.1)

  1. Data are mean ± SD. Mean difference between the diabetic and the nondiabetic in each CHF cohort is adjusted by age-squared, gender, hemoglobin, eGFR, LVEF, and log BNP
  2. AT, anaerobic threshold; HR, heart rate; RER, respiratory exchange ratio; VCO2, carbon dioxide production; VE, minute ventilation; VO2, oxygen uptake; 95% CI, 95% confidence interval
  3. * P < 0.05 vs. nondiabetics